Detailed answers about RISE AND REVIVE AFTER BREAST CANCER CIC, including incorporation, status, business activity, and accounts information.
When was RISE AND REVIVE AFTER BREAST CANCER CIC founded?
RISE AND REVIVE AFTER BREAST CANCER CIC was officially incorporated on 15 December 2025 and is registered under company number 16909784. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is RISE AND REVIVE AFTER BREAST CANCER CIC?
Community Interest Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of RISE AND REVIVE AFTER BREAST CANCER CIC?
RISE AND REVIVE AFTER BREAST CANCER CIC's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does RISE AND REVIVE AFTER BREAST CANCER CIC do?
RISE AND REVIVE AFTER BREAST CANCER CIC operates in the following sectors: 63990 - Other information service activities n.e.c., 85590 - Other education n.e.c., 86900 - Other human health activities, 90030 - Artistic creation. These SIC codes provide insight into the company's business activities and industry focus.
What is RISE AND REVIVE AFTER BREAST CANCER CIC's registered address?
The registered office address of RISE AND REVIVE AFTER BREAST CANCER CIC is INGENUITY LAB, UNIVERSITY OF NOTTINGHAM INNOVATION PARK,, TRIUMPH ROAD, NOTTINGHAM, NOTTINGHAMSHIRE, UNITED KINGDOM, NG7 2TU. This is the official address filed with Companies House for legal and statutory correspondence.
Is RISE AND REVIVE AFTER BREAST CANCER CIC financially stable?
Financial accounts for RISE AND REVIVE AFTER BREAST CANCER CIC are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.